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Abstract A yeast two-hybrid screen was utilized to identify
novel Smad 3 binding proteins expressed in developing mouse
orofacial tissue. Three proteins (Erbin, Par-3, and Dishevelled)
were identi¢ed that share several similar structural and func-
tional characteristics. Each contains at least one PDZ domain
and all have been demonstrated to play a role in the establish-
ment and maintenance of cell polarity. In GST (glutathione
S-transferase) pull-down assays, Erbin, Par-3, and Dishevelled
bound strongly to the isolated MH2 domain of Smad 3, with
weaker binding to a full-length Smad 3 protein. Failure of Er-
bin, Par-3, and Dishevelled to bind to a Smad 3 mutant protein
that was missing the MH2 domain con¢rms that the binding site
resides within the MH2 domain. Erbin, Par-3, and Dishevelled
also interacted with the MH2 domains of other Smads, suggest-
ing broad Smad binding speci¢city. Dishevelled and Erbin mu-
tant proteins, in which the PDZ domain was removed, still
retained their ability to bind Smad 3, albeit with lower a⁄nity.
While transforming growth factor L (TGFL) has been suggested
to alter cell polarity through a Smad-independent mechanism
involving activation of members of the RhoA family of GTP
binding proteins, the observation that Smads can directly inter-
act with proteins involved in cell polarity, as shown in the
present report, suggests an additional means by which TGFL
could alter cell polarity via a Smad-dependent signaling mech-
anism.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Transforming growth factor L (TGFL) is a member of a
large superfamily of growth and di¡erentiation factors com-
posed of three subfamilies: the TGFLs, activins/inhibins, and
bone morphogenetic proteins (reviewed in [1]). The TGFLs
elicit a wide variety of biological actions including embryonic
morphogenesis, cell proliferation, cell di¡erentiation, apopto-
sis, and extracellular matrix synthesis [1]. TGFL exerts its
in£uence on cells by altering patterns of gene expression
such as those genes controlling extracellular matrix synthesis
(e.g. collagen, collagenase, tenascin, matrix metalloprotei-
nases, and the plasminogen activator inhibitor 1) [2^5] and
those genes controlling cell proliferation (e.g. c-myc and
JunB) [6,7].
The TGFL signaling cascade is initiated by binding of
TGFL to a type II receptor-serine/threonine kinase (TLRII)
that then heterodimerizes with a type I receptor (TLRI, also a
serine/threonine kinase), resulting in phosphorylation of TLRI
by TLRII (reviewed in [1]). Activated (phosphorylated) TLRI
subsequently recruits and phosphorylates a class of proteins
termed Smads. The Smad proteins function as transducers of
TGFL signaling and are categorized in three distinct groups
based on function and sequence homology (receptor-regu-
lated, common, and inhibitory). Receptor-regulated Smads
(R-Smads), which are substrates for phosphorylation by
TGFL type I receptors, are further divided into those regu-
lated by TGFL/activin (Smads 2 and 3) and those regulated by
bone morphogenetic proteins (Smads 1, 5, and 8). Smad 4 is a
‘common’ Smad that heterodimerizes with phosphorylated R-
Smads. This Smad complex then translocates into the nucleus.
Inside the nucleus, the Co-Smad/R-Smad complex binds to
speci¢c sequences within the promoters of TGFL-responsive
genes and, depending on the cell type or gene, either stimu-
lates or represses transcription. Transcriptional activation by
Smads occurs with the aid, in part, of nuclear coactivators
such as CBP and p300 [8]. Conversely, transcriptional repres-
sion is e¡ected by interaction with nuclear corepressors such
as SnoN and c-Ski [9,10]. Thus, depending on the particular
cellular complement of nuclear coactivators and corepressors,
the transcriptional outcome of Smad/DNA binding will vary.
Although Smads are capable of directly binding DNA, they
do so with low a⁄nity [11]. High a⁄nity binding of Smads to
DNA requires additional cofactors for the full transcriptional
response [12].
TGFL family members are critical regulators of mammalian
orofacial development in that they are expressed in precise
spatio-temporal patterns in the developing orofacial region
and act speci¢cally through control of cellular proliferation
and di¡erentiation in the tissue [13,14]. Mouse knock-out ex-
periments have provided compelling evidence that fusion of
the developing secondary palatal shelves requires TGFL3-in-
duced medial edge epithelial (MEE) transdi¡erentiation [15], a
process wherein MEE cells di¡erentiate into a mesenchymal
phenotype via epithelio-mesenchymal transformation (EMT)
[16]. The critical role of TGFL signalling in orofacial develop-
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ment and the likelihood that cell- and tissue-speci¢c responses
to TGFL are mediated by cell- and tissue-speci¢c Smad co-
factors prompted a search for unique Smad binding proteins
expressed in embryonic orofacial tissue. A yeast two-hybrid
assay was employed in which the MH2 domain of Smad 3 was
used to screen an expression library derived from mouse em-
bryonic orofacial tissue. Three proteins have been identi¢ed
from this screen that share similar structural and functional
characteristics. Dishevelled-1 (Dvl-1), a protein intermediate
in the Wnt signaling pathway [17], Par-3, a protein originally
identi¢ed in Caenorhabditis elegans mutants exhibiting defects
in partitioning (cell polarity) [18], and Erbin, a recently iden-
ti¢ed protein that binds to the Erbb2 receptor [19]. Dvl-1,
Par-3, and Erbin are all PDZ (PSD-95, Discs-large, and
ZO-1) domain containing proteins that have been implicated
in establishment and maintenance of cell polarity.
The present report provides a preliminary characterization
of the interaction between Smad 3 and these three novel Smad
binding proteins (Dvl-1, Erbin, and Par-3). To our knowledge,
this is the ¢rst report of cross-talk between the TGFL and
Wnt signaling pathways at the level of Dvl and the ¢rst report
of an interaction between Smads and cell polarity proteins
(Par-3 and Erbin).
2. Materials and methods
2.1. Animals
ICR mice (Harlan, Indianapolis, IN), were maintained at a temper-
ature of 22‡C with an alternating light/dark cycle and were provided
access to food and water ad libitum. Mature male and female mice
were mated overnight and the presence of a vaginal plug the following
morning was taken as evidence of mating (gestation day 0). Pregnant
mice were euthanized on days 11^13 of gestation, a critical stage of
murine orofacial development. Embryos were removed from pregnant
dams, embryonic maxillofacial tissue was dissected in sterile, cold
phosphate-bu¡ered saline, and RNA was extracted from embryonic
tissue according to established protocols.
2.2. Yeast two-hybrid embryonic orofacial tissue expression library
RNA was isolated from mouse embryonic maxillary tissue har-
vested from embryos collected on days 11^13 of gestation. The ex-
pression library was prepared by Research Genetics, Inc. (Huntsville,
AL) and has an average insert size of 2.0 kb. In order to generate the
library, embryonic orofacial cDNAs were inserted into the pGADT7
vector (Clontech, Palo Alto, CA) which previously had been modi¢ed
to remove the existing NotI site at position 4520. A linker encoding
a NotI site £anked by BamHI sites was inserted into the unique
BamHI site within the multi-cloning sequence of pGADT7. Embry-
onic orofacial cDNAs were then inserted into the EcoRI^NotI site
of the modi¢ed pGADT7 vector to generate the ¢nal expression li-
brary.
2.3. Construction of fusion proteins with Smad 3 or Smad 3 MH2
domain and the Gal 4 DNA binding domain
Full-length human Smad 3 cDNA (in pcDNA3, Invitrogen, Carls-
bad, CA) was obtained from Dr. H. Heldin (Ludwig Institute for
Cancer Research, Uppsala, Sweden). To create a Gal4 DNA binding
domain^Smad 3 fusion protein (‘bait’), the Smad 3 cDNA was re-
leased by digestion with EcoRI and XhoI. The resulting 1.4 kb Smad 3
cDNA was ligated into EcoRI/SalI-digested pGBKT7 (Clontech)
downstream of the DNA binding domain of Gal4. To generate an
additional ‘bait’ construct, with the MH2 domain of Smad 3, poly-
merase chain reaction (PCR) was used to amplify the portion of the
cDNA encoding amino acid residues 239^424. An EcoRI site was
inserted at the 5P-end of the fragment, and the existing XhoI site at
the 3P-end was maintained. The limits of the MH2 domain were
chosen based on the crystal structure of the Smad 4 MH2 domain
[11]. The sequence of the forward PCR primer was 5P-CGG-
AATTCGCCTTCTGGTGCTCCATCTCC-3P and the reverse primer
was 5P-CATGCTCGAGCTAAGACACACTGG-3P. The PCR prod-
uct was digested with EcoRI and XhoI and inserted into pGBKT7
digested with EcoRI and SalI (downstream of the Gal4 activation
domain). All constructs were sequenced to verify integrity of the con-
structs. Furthermore, synthesis of either full-length Smad 3 protein or
the 24 kDa MH2 domain of the Smad 3 protein was tested via in vitro
transcription/translation using the TNT T7 coupled transcription/
translation system from Promega (Madison, WI) and [35S]L-methio-
nine (Perkin-Elmer Lifesciences, Boston, MA).
2.4. Yeast two-hybrid screen
pGBKT7-Smad 3 MH2 was cotransformed into Saccharomyces ce-
revisiae, strain AH109, along with the embryonic orofacial tissue ex-
pression library and plated onto yeast medium lacking histidine, leu-
cine, tryptophan, adenine, and supplemented with 2.5 mM 3-amino-
1,2,4,-triazole. The resulting transformants (approximately 5U105)
were replica-plated to the same type of plates supplemented with
20 Wg/ml X-K-gal. Blue colonies with the Hisþ/Leuþ/Trpþ/Adeþ phe-
notype were cultured and the plasmids were isolated using stan-
dard protocols [20]. Clones were re-introduced into yeast strain
AH109 along with either empty pGBKT7, pGBKT7-Smad 3 MH2,
pGBKT7-Smad 3 (full-length) or pGBKT7-lamin C (negative control)
to verify the Smad:clone interaction. Clones maintaining the Hisþ/
Leuþ/Trpþ/Adeþ/X-K-galþ phenotype were sequenced. Individual
clones were then transcribed and translated in vitro to insure proper
synthesis of each protein and determine the encoded protein’s molec-
ular weight.
2.5. Glutathione S-transferase (GST) pull-down assay
GST-fusion protein constructs for GST pull-down assays included
those for: Smad 1, Smad 1 MH2, Smad 2, Smad 2 MH2, Smad 3,
Smad 3 MH2, Smad 4, Smad 4 MH2, Smad 7, and Smad 7 MH2. To
generate GST-fusion constructs for GST pull-down assays with full-
length Smad 3 or Smad 3 MH2, each cDNA was subcloned from
pGBKT7 into pGEX-5X-1 (Amersham Biosciences, Piscataway,
NJ). pGEX2TK-human Smad 1 was provided by Dr. X. Lin (Baylor
University, Houston, TX), pGEX4T2-mouse Smad 2 and pGEX4T2-
human Smad 4 were provided by Dr. Y. Chen (Indiana University,
Indianapolis, IN) and pGEX4T-1-Smad 3 vMH2 was obtained from
Dr. M. Kato (Japanese Foundation for Cancer Research, Tokyo,
Japan). pGEX-5X-1 Smads 1-, 2-, and 4-MH2 domains were gener-
ated by PCR with primers speci¢c for the MH2 domains, and utilizing
full-length cDNA’s as the template. The MH2 domains encompass
amino acid residues 269^465 (Smad 1), 272^467 (Smad 2) and 321^
552 (Smad 4). pGEX-5X-1 Xenopus Smad 7 full-length and Smad 7
MH2 domain (amino acid residues 214^390, based on sequence ho-
mology with the MH2 domain of Smads 1^5 and 8) were constructed
by performing PCR on pBluescript II SK containing full-length Xeno-
pus Smad 7, provided by Dr. H. Brivanlou (Rockefeller University,
New York, NY). All constructs were veri¢ed by DNA sequencing.
Each was transformed into Escherichia coli BL21, and GST-fusion
protein expression was induced with 0.3 mM isopropyl thio-L-D-gal-
actopyranoside for 6 h. Preparation of cleared lysates and puri¢cation
of the fusion proteins were as described [20]. Approximately 1 Wg of
GST-fusion protein was mixed with 5 Wl in vitro translated, [35S]-
labeled Dvl-1, Par-3, or Erbin protein in GST pull-down bu¡er (20
mM Tris, [pH 7.5], 150 mM NaCl, 0.1% NP-40, 1 mM dithiothreitol,
10% glycerol, 1 mM EDTA, 2.5 mM MgCl2, 1 Wg/ml aprotinin, and
1 Wg/ml leupeptin). The reaction was incubated for 2 h at 4‡C with
rotation, and the sepharose beads washed four times with 0.4 ml GST
pull-down bu¡er. Bound protein was released by the addition of
2U Laemmli sample bu¡er [21] followed by incubation for 5 min at
95‡C. The eluted sample was analyzed by sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE). The gels were ¢xed
with 50% methanol:10% acetic acid and exposed to Kodak X-Omat
¢lm for 2 days at 380‡C. Following autoradiography, each gel was
stained with Coomassie blue to determine loading e⁄ciency for each
sample.
2.6. K-Galactosidase assay
Secreted K-galactosidase was measured from log-phase cultures of
yeast cotransformed with Smad 3 MH2 and Dvl-1 or Erbin deletion
mutants. Hydrolysis of p-nitrophenyl K-D-galactopyranoside was de-
termined by spectrophotometrically measuring released p-nitrophenol
(lambda max= 410 nm) according to procedures described by Clon-
tech (Palo Alto, CA).
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3. Results
3.1. Yeast two-hybrid screen for Smad binding proteins
In order to contribute to a better understanding of TGFL
signaling mechanisms in mammalian orofacial development, a
yeast two-hybrid screen of an expression library generated
from RNA isolated from the orofacial region of gestational
days 11^13 embryos was performed using the MH2 domain of
the TGFL-responsive Smad 3. Numerous Smad 3-interacting
proteins were identi¢ed from a screen of approximately
5U105 yeast transformants. Three of these binding proteins
are described in this report : (1) Dvl-1, an intermediate in the
Wnt signaling pathway [17] ; (2) Erbin, a recently reported
protein that interacts with the Erbb2 receptor [19], and (3)
Par-3, a protein which, when mutated, confers a partitioning
defect in C. elegans [27]. These three proteins have been
grouped in the present report based on the presence of a
common structural motif and known function. All of these
proteins have at least one PDZ domain and have been dem-
onstrated to function in controlling cell polarity and/or asym-
metric cell division. PDZ domains are modular domains of
approximately 80 amino acids that mediate protein^protein
interactions, generally those involved in targeting proteins to
speci¢c locations within the cell (reviewed in [22]). These do-
mains were originally identi¢ed in PSD-95, Discs-large, and
ZO-1, hence the acronym, PDZ.
To demonstrate speci¢city of binding, plasmid was isolated
from each positive two-hybrid clone and introduced back into
S. cerevisiae along with either full-length Smad 3, Smad 3
MH2 domain, or lamin C fused to the DNA binding domain
of Gal 4, or empty vector (Gal 4 DNA binding domain
alone). Neither Smad 3 nor the MH2 domain of Smad 3
resulted in activation of the reporter genes (data not shown).
Cotransformed yeast were plated onto high-stringency me-
dium (Fig. 1). Growth occurred only in the presence of either
full-length Smad 3 or the MH2 domain of Smad 3, demon-
strating that Erbin, Par-3, and Dvl-1 all interacted with both
full-length Smad 3 and the isolated MH2 domain in this as-
say.
Each cDNA isolated for these three two-hybrid clones en-
coded truncated proteins missing their amino termini. The
limits of the clones and the positions of conserved domains
are illustrated in Fig. 2. The clones for both Erbin and Dvl-1
contained either full or partial PDZ domains, respectively.
The Par-3 clone was missing a PDZ domain altogether.
Full-length Erbin contains, in addition to the PDZ domain,
a leucine-rich region (LRR) at the amino terminus. Such LRR
domains have been suggested to mediate protein^protein in-
Fig. 1. Interaction between Smad 3 and Erbin, Par-3, and Dvl-1 in a yeast two-hybrid assay. Growth of transformed S. cerevisiae on high-strin-
gency plates (see Section 2) demonstrating an interaction between either Smad 3 MH2 or full-length Smad 3 and Erbin, Dvl-1, or Par-3.
pGBKT7-Smad 3 MH2, pGBKT7-h Smad 3 (full-length), pGBKT7-lamin C, or empty pGBKT7 were cotransformed with pGADT7-Erbin,
pGADT7-Dvl-1, or pGADT7-Par-3 into S. cerevisiae AH109 and initially plated onto low-stringency plates (see Section 2). Colonies were then
re-streaked onto high-stringency plates in the presence of X-K-gal. Note growth and blue color when Erbin, Dvl-1, or Par-3 were cotransformed
with either full-length Smad 3 or its MH2 domain but not with empty pGADT7 or pGADT7-lamin C.
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teractions [23]. The Dvl clone corresponded to Dvl isoform 1
[24]. In addition to a PDZ domain, full-length Dvl-1 contains
domains found in other proteins. The DIX domain of Dvl is
similar to that found in Axin which mediates formation of a
protein^protein complex between Dvl isoforms and Axin [25].
The DEP domain of Dvl shares homology to domains found
in proteins such as the product of the C. elegans egl-10 gene
and pleckstrin [26]. The Par-3 clone corresponded to the re-
ported 180 kDa form and contained no discernable domains
[18].
3.2. Erbin, Par-3, and Dvl-1 preferentially interact with the
MH2 domains of several Smads
To con¢rm the Smad^protein interaction in vitro and to
determine if Erbin, Par-3, and Dvl-1 bind other Smad pro-
teins, Smad proteins from each class (receptor-regulated, com-
mon, and inhibitory) were expressed in E. coli as a fusion
protein with GST and the fusion proteins were puri¢ed on
glutathione beads. In vitro translated, [35S]methionine-labeled
Erbin, Par-3, and Dvl-1 were individually mixed with puri¢ed
GST^Smads and ‘pulled-down’ with glutathione^agarose
beads. All three proteins interacted with the isolated MH2
domain of Smad 3 (Fig. 3) which is consistent with the data
from the yeast two-hybrid screen (Fig. 1). In addition to Smad
3 MH2, Erbin bound to the MH2 domains of Smads 2, 4 and
7 and with weaker binding to the MH2 domain of Smad 1.
Erbin bound poorly to full-length versions of Smads 1, 4, and
7. Dvl-1 exhibited a pattern of binding similar to Erbin with
the exception that binding to full-length Smad 7 was greater
than with the isolated Smad 7 MH2 domain. Par-3 bound
poorly to all full-length Smads, with the notable exception
of Smad 7, in which binding was more e⁄cient than the iso-
lated MH2 domain. In contrast to both Erbin and Dvl-1, Par-
3 bound weakly to Smads 1 and 2 (either full-length and MH2
domain). These data demonstrate that Erbin, Par-3, and Dvl-
1 exhibit broad speci¢city of binding to Smads, with a pref-
erence for the Smad MH2 domain (with the obvious exception
of Smad 7). All three of these proteins bound ine⁄ciently to a
mutant of Smad 3 in which the MH2 domain was deleted
(Smad 3 vMH2, Fig. 3), demonstrating that the site of inter-
action lies within the MH2 domain. Additionally, no interac-
tion was observed with GST alone.
3.3. PDZ domains do not bind Smads
To determine if the PDZ domains of Erbin and Dvl-1 con-
fer the ability to interact with Smad 3, deletion mutants were
constructed to remove the PDZ domains of these two pro-
teins. Each mutant cDNA was transformed into yeast along
with the MH2 domain of Smad 3. The strength of interaction
was tested by measuring the secretion of K-galactosidase,
which is directly proportional to the strength of the protein^
Smad 3 interaction. As shown in Table 1, deletion of the PDZ
domain reduced binding to Smad 3 by approximately 50% for
both Dvl-1 (Dvl-1 vPDZ) and Erbin (Erbin vPDZ). An iso-
lated PDZ domain of Erbin (Erbin PDZ domain) failed to
bind Smad 3 MH2. These data demonstrate that the PDZ
domains of Dvl-1 and Erbin are not solely responsible for
interaction with Smad 3 MH2. Dvl-1 also contained an addi-
tional domain commonly found in GTP binding proteins
termed the DEP domain. Deletion of this domain (Dvl-1
vDEP), reduced Smad 3 binding to one-third that of the
Fig. 3. GST pull-down assay between Erbin, Par-3, or Dvl-1 and various Smads. GST^Smad fusion proteins were expressed and puri¢ed from
E. coli. Approximately 1 Wg GST^Smad fusion protein was mixed with [35S]methionine-labelled, in vitro translated Erbin, Par-3, or Dvl-1 (trun-
cated versions isolated during the two-hybrid screen), precipitated with glutathione^agarose and analyzed by SDS^PAGE and autoradiography.
The autoradiograms presented are representative of three independent experiments and con¢rm binding of Par-3, Erbin, and Dvl-1 to Smad 3
MH2 and identi¢es binding to additional Smads. ‘Input’ lane demonstrates the signal from 10% of the amount of in vitro translated protein
present in each sample.
Fig. 2. Schematic illustrating the position of the clones isolated in
the yeast two-hybrid screen in relation to their full-length counter-
parts. The domain organization of full-length Erbin, Par-3, and
Dvl-1 was obtained from primary references [18,19,24]. For the pur-
pose of the present study, the intervening regions of Dvl-1 are arbi-
trarily labelled I, II, and III.
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full-length Dvl-1 clone, demonstrating that it plays a role in
Smad 3 binding. Finally, mutation of the sequences between
the PDZ and DEP domains of Dvl-1 and the carboxyl-termi-
nal 195 amino acids was carried out to determine their func-
tion in Smad 3 binding. When the PDZ and DEP domains
were moved next to each other (Dvl-1 vII), only 6.6% of the
level of binding to Smad 3 obtained from the unmodi¢ed Dvl-
1 was detected, suggesting an important role for this interven-
ing sequence. When the Dvl-1 clone was split in half (Dvl-1
vDEP/III and Dvl-1 vPDZ/II), each half resulted in similar K-
galactosidase activity, (15^20%) of maximal activity. These
data suggest that both the PDZ and DEP domains provide
binding platforms for Smad 3 and that proper spacing be-
tween the two is crucial for e⁄cient binding. For Dvl-1, delet-
ing any series of amino acids signi¢cantly decreased binding
to Smad 3 MH2. The greatest e¡ect on Dvl-1 binding to
Smad 3 MH2 occurred when the sequence between the PDZ
and DEP domains was removed (domain II). This suggests
that either domain II confers Smad 3 binding or that the
spacing between PDZ and DEP domains is critical.
4. Discussion
TGFL signaling through Smads is critical for a variety of
cellular and developmental processes (reviewed in [1]). To fur-
ther our understanding of TGFL-directed, Smad-dependent
signaling in developing orofacial tissue, a yeast two-hybrid
screen was employed to identify unique Smad binding pro-
teins. In the present report, three novel proteins that interact
with Smad 3 are identi¢ed. These Smad binding proteins pos-
sess a common structural motif in that each has at least one
PDZ domain. Moreover, they share a common function in
that each has been shown to be involved in establishing
and/or maintaining cell polarity. PDZ domains are small,
modular protein domains of 80^90 amino acids that bind to
sequences typically found within the carboxyl terminus of
target proteins (reviewed in [22]). They provide a platform
for the assembly of multi-protein complexes that are targeted
to speci¢c subcellular locations. PDZ domains were ¢rst de-
scribed in PSD-95, the Drosophila septate junction protein,
Discs-large, and the mammalian tight junction protein, ZO-
1 (thus, the abbreviation, PDZ). PDZ domain-containing pro-
teins have been implicated in the establishment of cell polarity
and the asymmetric distribution of cellular components found
in certain cells with specialized functions. Examples include
mammalian epithelial cells with apico-basolateral polarity and
the axonic-dendritic specialization of neuronal cells. In devel-
opment, cell polarity can lead to asymmetric cell division in
which cell fate determinants are unequally distributed to
daughter cells. As such, cell polarity serves as an important
mechanism for generating cell fate diversity. Insight into the
phenomenon of cell polarity has been gained predominately
through the study of several model systems, particularly the
zygote of C. elegans, the germline cyst of Drosophila, and
mammalian epithelial cells.
In C. elegans, the major genes that control cell polarity are
the Par genes, so-called because mutations in these genes lead
to partitioning defects in the early zygote [27]. Several of the
Par proteins contain PDZ domains. Par-3 and Par-6 contain
three and one PDZ domains, respectively. In C. elegans, Par-3
was demonstrated to be the nucleation center for a complex
that includes Par-6 and an atypical protein kinase (aPKC)
[18]. This Par-3/Par-6/aPKC complex determines the position
of the anterior portion of the zygote. Likewise, in mammalian
epithelial cells, a homologous tripartate complex is found in
tight junctions localized to the apical cellular surface [28]. In
Drosophila epithelial and neural precursors (where the Par-3
homologue is called Bazooka), a similar complex is involved
in determining apico-basolateral polarity of epithelial cells
and the apical crescent of dividing neuroblasts [29,30]. The
involvement of this tripartate protein complex in controlling
cell polarity in diverse organisms suggests a mechanism con-
served during evolution. Par-3 binds to Par-6 via a PDZ^PDZ
domain-mediated interaction [18]. Recently, additional com-
ponents of the Par-3/Par-6/aPKC complex have been identi-
¢ed. The Rho family members Cdc42 and Rac1 have been
found to bind the Par-3/Par-6/aPKC complex through speci¢c
interactions with Par-6 [31]. Since only the GTP form binds
e⁄ciently to Par-6, it has been suggested that the activity of
the complex is regulated through GTP binding. The involve-
ment of Cdc42 and Rac1 in cytoskeletal rearrangement, a
process crucial to asymmetric cell division, has been demon-
strated previously (reviewed in [32]).
In Drosophila epithelia, apical localization of the Par-3/Par-
6/aPKC tripartate complex depends upon three additional
proteins: the LAP (leucine-rich region and PDZ domain) pro-
tein Scribble, Discs-large (Dlg), and Lethal Giant Larvae [31].
In C. elegans, cell polarity requires the LAP protein LET-413
[33]. LAP proteins are a recently described class that is char-
acterized by an amino-terminal LRR and one to four PDZ
domains. This class of proteins includes LET-413, Scribble,
Densin-180, Lano (Lano is an exception and does not contain
a PDZ domain), and Erbin. Erbin is the mammalian homo-
logue of C. elegans LET-413. Erbin is localized to the baso-
lateral surface of epithelial cells, binds the Erbb2 receptor and
targets it to this region of the cell [19]. LAP proteins also have
been implicated in controlling the position of adherens junc-
Table 1
Deletion mapping of Dvl and Erbin Smad 3 binding domains
cDNA K-Galactosidase activity
(% of unmodi¢ed protein)
Dvl-1 100*
Dvl-1 vPDZ 43.1V 4.1
Dvl-1 vDEP 32.1V 3.0
Dvl-1 vII 6.6V 1.5
Dvl-1 vDEP/III 22.0V 3.3
Dvl-1 vPDZ/II 15.3V 1.2
Erbin 100**
Erbin vPDZ 50.9V 3.0
Erbin PDZ domain 0.9V 0.9
Dvl-1 and Erbin deletion constructs in pGADT7 were introduced
into S. cerevisiae AH109 along with the cDNA for the MH2 do-
main of Smad 3 (in pGBKT7), plated onto SD/-Leu/-Trp plates,
and incubated for 3 days. Transformants were used to establish log-
phase liquid cultures, from which the levels of K-galactosidase se-
creted into the media were determined by measuring hydrolysis of
PNP-K-gal. The data, representative of three independent experi-
ments, are reported as the meanV range of replicate determinations.
Data are expressed as percentage of K-galactosidase activity com-
pared to the unmodi¢ed protein (which is set to 100%), and are
normalized to cell culture density. Background activity, which was
determined by cotransforming each test plasmid with lamin C, was
subtracted for ¢nal presentation of the data and ranged from 0.1 to
1.3 mU/ml, for Dvl-1 and Erbin, respectively. The absolute values
for K-galactosidase activity for unmodi¢ed proteins were: *15.0V 0.7
and **10.7V 0.5 mU/ml. ‘Unmodi¢ed protein’ refers to the clone
isolated in the two-hybrid screen.
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tions. Erbin has several interaction partners, including pro-
teins that bind the cytoskeleton and desmosomes [34].
In Drosophila, a di¡erent type of polarity, planar cell polar-
ity or tissue polarity, controls the development of sensory
bristles. Planar cell polarity is controlled in part by products
of the genes frizzled and Dvl, both members of the Wnt sig-
naling pathway (reviewed in [35]). Frizzled is the receptor for
the Wnt ligand and Dvl serves as the control point to direct
Wnt signals either: (1) to the canonical pathway leading to
L-catenin accumulation and regulation of gene expression
through the TCF/LEF family of transcription factors or
(2) to the planar cell polarity pathway, mediated through
the Jun N-terminal kinase (JNK) [36]. Distinct domains in
Dvl control each of these processes. The DIX and PDZ do-
mains control the canonical pathway while the DEP domain is
responsible for mediating activation of the JNK pathway [36].
The data presented in the current report demonstrate that
Smad 3 binds to three proteins with well-documented roles in
cell polarity suggesting that TGFL-activated Smads are in-
volved in the establishment of cell polarity. Although TGFL
has not been previously shown to be directly involved in cell
polarity, it has been linked to promotion of EMT, a process
characterized by loss of cell polarity, delocalization of E-cad-
herin from cell junctions, and the assumption of a more spin-
dle-shaped morphology [37^39]. EMT is an essential process
in early embryonic development when large-scale tissue reor-
ganization occurs [40]. In addition, TGFL has been demon-
strated to alter the cytoskeleton through a process dependent
on Cdc42 and RhoA [41]. Within the orofacial region, di¡er-
entiation of the MEE cells via EMT occurs subsequent to
fusion of the secondary palatal shelves and has been shown
to be regulated by TGFL [15]. The role of Erbin, Par-3, or
Dvl-1 in TGFL-mediated palatal fusion and epithelial trans-
formation is at present unknown.
Erbin and Par-3 are found in a broad distribution pattern
in adult tissues, with little information on their expression
during development [42,43]. However, Dvl-1 is expressed
throughout both adult and embryonic tissues [44]. We have
recently determined that Dvl-1 and Erbin are expressed in
developing palatal and maxillary tissue in the embryonic
mouse (data not shown). Whether if the interaction between
Smads and Erbin, Par-3, or Dvl-1 is speci¢c to craniofacial
tissue or is a more general phenomenon awaits further study.
Comparison of Erbin, Par-3, and Dvl-1 revealed no obvious
sequence similarity that would point to a Smad binding motif.
It is possible, however, that each possesses a similar tertiary
structure in the absence of primary sequence conservation.
The unique ability of Smads to bind to these three unique
proteins (Erbin, Par-3, and Dvl-1), which share structural
and functional characteristics, suggests a direct role for Smads
in Erbin-, Par-3-, and Dvl-1-mediated biological processes (in-
cluding, but not limited to, cell polarity). Since other classes
of Smads (e.g. the common Smad, Smad 4 and the inhibitory
Smad, Smad 7) also bind to these proteins, multiple levels of
regulation and crosstalk may exist between the Smad signaling
pathway and pathways involving Erbin, Par-3, and Dvl-1.
It is interesting that Erbin, Par-3, and Dvl-1 have higher
a⁄nity for the isolated MH2 domain, with the exception of
Smad7, in the case for Par-3 and Dvl-1. In the basal state, the
current model of Smad activation holds that the MH1 and
MH2 domains mutually inhibit one another and receptor-
mediated phosphorylation of the Smad C-terminus relieves
this inhibition. We propose, therefore, that exposure of the
MH2 domain through Smad activation is required for inter-
action with Erbin, Par-3, and Dvl-1. Although this may be the
case for Smads 1^4, full-length Smad 7 bound more strongly
to Par-3 and Dvl-1. The MH2 domain of Smad 7 is based
upon sequence homology to Smads 1^5, all of which have a
conserved MH2 domain. Thus, either additional structures
within Smad 7 (i.e. outside the MH2 domain) may be impor-
tant for binding to Dvl-1 and Par-3, or the structure of the
Smad 7 MH2 domain is altered by the presence of the amino-
terminal region making it a better binding partner than the
MH2 domain alone.
Additional in vivo cellular analyses, currently underway in
our laboratory, will provide insight into the role and biolog-
ical signi¢cance of the interaction between Smads and Erbin,
Par-3, and Dvl-1 in embryonic orofacial development.
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